Canadian Task Force on Preventive Health Care

Full Text Review

Screening for Congenital Hypothyroidism

Prepared by Marie-Dominique Beaulieu, MD, MSc, FCFP, Department of Family Medicine, University of Montreal

These recommendations were finalized by the Task Force in January 1994

Up Contents

UpOverview

The Canadian Task Force on the Periodic Health Examination concludes that there is good evidence to recommend screening for congenital hypothyroidism in newborns between 2 and 6 days of life. The maneuver consists of the measurement of thyroid-stimulating hormone (TSH) levels in a dried capillary blood sample, usually taken from the newborn’s heel. Thyroxine (T4) level is measured if necessary. This recommendation is unchanged from that made by the Task Force in 1990,<1> except that, reflecting current thinking regarding test characteristics, TSH is now considered the primary screening test followed by T4, if necessary (previous recommendation T4 followed by TSH).

Up Burden of Suffering

The incidence of congenital hypothyroidism ranges between 1 per 4,000 to 1 per 3,500 live births<2> and can be as high as 1 per 141 live births among infants with Down syndrome.<3> Before screening was available, the age at diagnosis ranged from 1 week to 5 years or more. The intelligence quotient (IQ) of 65% of patients with congenital hypothyroidism was below 85 (borderline intellectual functioning or lower), and in 19% it was below 15 (profound mental retardation).<4> It is estimated that about 30% of infants with delayed diagnosis would qualify for institutional care. Children whose mothers ingested iodides, propylthiouracil or radioactive iodine or had circulating antithyroid antibodies are at high risk for congenital hypothyroidism.

Up Maneuver

All industrialized countries now have well organized screening programs for congenital hypothyroidism. Most screening programs in Canada and in Europe use a two-step laboratory approach where TSH is measured first and T4 in borderline cases. However, many programs in the United States measure T4 first. The recall rate for T4 averages 1.1% with a positive predictive value of 2.4%.

Blood samples from the heel are collected on filter paper, ideally 3 to 6 days after birth, and tested for TSH concentration. TSH levels after the first 24 hours of life can be as high as 20 mIU/ml, thus increasing the number of false positive results. For this reason, newborns leaving the hospital in their first 24 hours of life are usually not tested.

The cut-off point for hypothyroidism is defined according to the daily standard deviation of test results rather than by a predetermined concentration. Since the laboratory method and the size of the blood spot influence the TSH and T4 levels each program must define its own standards and reference values. If the TSH level falls within normal limits the T4 concentration is measured with another blood spot on the filter paper. The recall rate with TSH testing averages 0.05%. At this rate, two infants are recalled for testing for every case detected. The sensitivity of the combined maneuver is about 95%.

Cases of primary, congenital hypothyroidism or about 5% of all cases of congenital hypothyroidism cannot be identified with the TSH screening approach.<5>

Up Effectiveness of Screening and Treatment

The first evidence of the benefits of screening for congenital hypothyroidism in Canada came with publication of the one-year follow-up data from the Quebec Screening Program.<6>

The mean IQ of affected infants less than 12 months of age was greater than 100, and did not differ from that of control subjects. Both the Quebec screening program and the New England Congenital Hypothyroidism Collaborative have published five-year follow-up data on children screened at birth.<7,8> The children who had been treated for congenital hypothyroidism were comparable to matched controls on all developmental scales. In the Quebec program, the IQ of the children treated for congenital hypothyroidism was within normal limits for children of their age, though the average IQ was statistically lower than that of the control group (105 vs. 110).<7>

Follow-up data up to 12 years after screening have recently been published.<9> The IQ and developmental scores of the hypothyroid children were still within normal limits. The degree of fetal hypothyroidism at birth influenced the final outcome.

The fact that most hypothyroid infants identified at birth by screening have intellectual and psychomotor development in the normal range, constitutes a dramatic improvement over the outcomes in children previously diagnosed later in life.

Up Recommendations of Others

Few Canadian organisations have issued recommendations on screening for thyroid diseases. The U.S. Preventive Services Task Force has recommended universal screening for congenital hypothyroidism.<10>

Up Conclusions and Recommendations

The dramatic change in the natural history of congenital hypothyroidism since the advent of screening warrants a grade A Recommendation, even in the absence of a randomized controlled trial. Thus, there is good evidence to recommend routine testing of all neonates.

Screening for congenital hypothyroidism is generally carried out by hospitals and is therefore outside the control of most individual physicians. Nonetheless, primary care physicians should make sure that all infants who are born at home or discharged from hospital within 24 hours after birth are tested for hypothyroidism within 7 days after birth. It is better to obtain a specimen within 24 hours than no specimen at all.

Up Evidence

Since the last review of the Task Force on thyroid diseases was published in 1990, a MEDLINE search between 1989 and 1993 was conducted. The search was done using congenital hypothyroidism with screening and prevention and control. Only original articles were considered. The search yielded few new articles. Priority was given to the highest levels of evidence according to the Task Force methodology. This review was initiated in February 1993 updating a report published in 1990.<1> Recommendations were finalized by the Task Force in January 1994.

 Full Citation

Link to Structured Abstract of this review

Link to Summary Table of this review

Link to Selected References list of this review

Top of Page

Home PageCTFPHC Home Page

Reprinted in modified format by the Canadian Task Force on Preventive Health Care
with permission.
For any technical issues please contact: webmaster@ctfphc.org
Original Copyright © 1994 Minister of Supply and Services Canada.
Last modified March 30, 1998.